![\"3DFragCons-logo\"](\"https:\/\/i0.wp.com\/generic.wordpress.soton.ac.uk\/dial-a-molecule\/wp-content\/blogs.dir\/sites\/50\/2013\/02\/3DFragCons-logo.png?resize=156%2C83\")
<\/a><\/h3>\n<\/td>\n\n![\"RS_Logotype_Black\"](\"https:\/\/i0.wp.com\/generic.wordpress.soton.ac.uk\/dial-a-molecule\/wp-content\/blogs.dir\/sites\/50\/2013\/02\/RS-logo-stacked_black_A4.jpg?resize=180%2C121\")
<\/a><\/h3>\n<\/td>\n\n![\"UniHudd-logo\"](\"https:\/\/i0.wp.com\/generic.wordpress.soton.ac.uk\/dial-a-molecule\/wp-content\/blogs.dir\/sites\/50\/2013\/02\/UniHudd-logo.png?resize=159%2C103\")
<\/a><\/h3>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\nA Dial-a-Molecule EPSRC Grand Challenge theme event<\/h3>\n
When:<\/strong> 5 February 2013<\/em>
\nWhere:<\/strong> 3M Buckley Innovation Centre, University of Huddersfield (http:\/\/www.3mbic.com\/)<\/em><\/p>\nThe last 10 years have seen a radical restructuring of global pharma R&D in response to the increasingly challenging process of discovering, progressing and launching a new drug. A consequence of this business remodelling has been the tapering of UK synthetic and medicinal chemistry capacity; this offers an opportunity for academic synthetic chemists to generate impact in the drug discovery process, especially in the hit\/lead identification phase of the drug pipeline. The 3D Fragment Consortium is an EPSRC-funded network, which aims to expand the chemical space of drug discovery by leveraging novel class-leading academic synthetic chemistry. Access to such cutting-edge synthetic expertise will empower and enable the study of drug target classes previously lacking high quality chemical start points; such as protein-protein interactions. Given the UK strength in chemical synthesis, a chemical consortium focused upon the implementation of powerful synthetic methods would be perfectly placed to design and deliver novel three-dimensional chemical libraries for fragment screening to complement existing fragment libraries. The consortium would also be able to contribute to the generation of useful chemical start points for a broad range of target therapeutic classes.<\/p>\n
As part of the Royal Socie<\/strong>ty Year of Science and Indu<\/strong>stry<\/strong>, and in collaboration with the \u2018Dial-a-Molecule\u2019 EPSRC Grand Challenge Network<\/strong> and SMSDrug.net<\/strong>, on 5 February 2013 the 3D Fragment Consortium<\/strong> will host a workshop meeting at which the opportunities and benefits for academic synthetic chemists will be presented. In particular, the workshop will discuss:
\n\u2022\u00a0\u00a0 \u00a0how class-leading academic synthesis can be used in a drug discovery context
\n\u2022\u00a0\u00a0 \u00a0the key features of fragment libraries, and their relevance to cutting-edge research groups
\n\u2022\u00a0\u00a0 \u00a0the tools available to enable synthetic chemists to make contributions to the drug discovery process
\n\u2022\u00a0\u00a0 \u00a0constructing an inclusive network of med chem-facing academic chemists
\n\u2022\u00a0\u00a0 \u00a0funding possibilities
\n\u2022\u00a0\u00a0 \u00a0how to deal with IP issues<\/p>\nThe key deliverable of the event will be the creation of a blueprint for successful collaborations between academic chemists and drug-hunting organisations.<\/p>\n
Program:<\/strong><\/span><\/p>\n\n\n\n10:00<\/strong><\/td>\nRegistration<\/strong><\/td>\n<\/tr>\n\n10:30<\/strong><\/td>\nOpening remarks<\/strong><\/td>\n<\/tr>\n\n<\/td>\n Joe Sweeney & Andy Morley<\/em><\/td>\n<\/tr>\n\n10:40<\/strong><\/td>\nLecture 1:<\/strong> Dr Stuart Conway (University of Oxford)<\/em><\/td>\n<\/tr>\n\n11:00<\/strong><\/td>\nLecture 2: <\/strong>Prof Greg Challis (University of Warwick)<\/em><\/td>\n<\/tr>\n\n11:20<\/strong><\/td>\nLecture 3:<\/strong> Dr Paul Brennan (Structural Genomics Consortium)<\/em><\/td>\n<\/tr>\n\n12:15<\/strong><\/td>\nLunch<\/strong><\/td>\n<\/tr>\n\n13:30<\/strong><\/td>\nDiscussion session 1: 1000 Click Reactions<\/strong><\/td>\n<\/tr>\n\n14:15<\/strong><\/td>\nDiscussion session 2: Create scaffold diversity using academic research<\/strong><\/td>\n<\/tr>\n\n15:00<\/strong><\/td>\nTea\/coffee<\/strong><\/td>\n<\/tr>\n\n15:30<\/strong><\/td>\nDiscussion session 3: Tools to enable academics to contribute to drug discovery<\/strong><\/td>\n<\/tr>\n\n16:15<\/strong><\/td>\nDiscussion forum: IP issues<\/strong><\/td>\n<\/tr>\n\n16:30<\/strong><\/td>\nConclusions and close of meeting<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n <\/p>\n
\n\n\n![\"SMSDrugNet-logo\"](\"https:\/\/i0.wp.com\/generic.wordpress.soton.ac.uk\/dial-a-molecule\/wp-content\/blogs.dir\/sites\/50\/2013\/02\/SMSDrugNet-logo.png?resize=216%2C69\")
<\/a><\/td>\n![\"3MBIC-logo\"](\"https:\/\/i0.wp.com\/generic.wordpress.soton.ac.uk\/dial-a-molecule\/wp-content\/blogs.dir\/sites\/50\/2013\/02\/3MBIC-logo.png?resize=164%2C85\")
<\/a><\/td>\n![\"DaM-logo\"](\"https:\/\/i0.wp.com\/generic.wordpress.soton.ac.uk\/dial-a-molecule\/wp-content\/blogs.dir\/sites\/50\/2013\/02\/DaM-logo.png?resize=137%2C87\")
<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
<\/a><\/h3>\n<\/td>\n\n<\/a><\/h3>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\nA Dial-a-Molecule EPSRC Grand Challenge theme event<\/h3>\n
When:<\/strong> 5 February 2013<\/em>
\nWhere:<\/strong> 3M Buckley Innovation Centre, University of Huddersfield (http:\/\/www.3mbic.com\/)<\/em><\/p>\nThe last 10 years have seen a radical restructuring of global pharma R&D in response to the increasingly challenging process of discovering, progressing and launching a new drug. A consequence of this business remodelling has been the tapering of UK synthetic and medicinal chemistry capacity; this offers an opportunity for academic synthetic chemists to generate impact in the drug discovery process, especially in the hit\/lead identification phase of the drug pipeline. The 3D Fragment Consortium is an EPSRC-funded network, which aims to expand the chemical space of drug discovery by leveraging novel class-leading academic synthetic chemistry. Access to such cutting-edge synthetic expertise will empower and enable the study of drug target classes previously lacking high quality chemical start points; such as protein-protein interactions. Given the UK strength in chemical synthesis, a chemical consortium focused upon the implementation of powerful synthetic methods would be perfectly placed to design and deliver novel three-dimensional chemical libraries for fragment screening to complement existing fragment libraries. The consortium would also be able to contribute to the generation of useful chemical start points for a broad range of target therapeutic classes.<\/p>\n
As part of the Royal Socie<\/strong>ty Year of Science and Indu<\/strong>stry<\/strong>, and in collaboration with the \u2018Dial-a-Molecule\u2019 EPSRC Grand Challenge Network<\/strong> and SMSDrug.net<\/strong>, on 5 February 2013 the 3D Fragment Consortium<\/strong> will host a workshop meeting at which the opportunities and benefits for academic synthetic chemists will be presented. In particular, the workshop will discuss:
\n\u2022\u00a0\u00a0 \u00a0how class-leading academic synthesis can be used in a drug discovery context
\n\u2022\u00a0\u00a0 \u00a0the key features of fragment libraries, and their relevance to cutting-edge research groups
\n\u2022\u00a0\u00a0 \u00a0the tools available to enable synthetic chemists to make contributions to the drug discovery process
\n\u2022\u00a0\u00a0 \u00a0constructing an inclusive network of med chem-facing academic chemists
\n\u2022\u00a0\u00a0 \u00a0funding possibilities
\n\u2022\u00a0\u00a0 \u00a0how to deal with IP issues<\/p>\nThe key deliverable of the event will be the creation of a blueprint for successful collaborations between academic chemists and drug-hunting organisations.<\/p>\n
Program:<\/strong><\/span><\/p>\n\n\n\n10:00<\/strong><\/td>\nRegistration<\/strong><\/td>\n<\/tr>\n\n10:30<\/strong><\/td>\nOpening remarks<\/strong><\/td>\n<\/tr>\n\n<\/td>\n Joe Sweeney & Andy Morley<\/em><\/td>\n<\/tr>\n\n10:40<\/strong><\/td>\nLecture 1:<\/strong> Dr Stuart Conway (University of Oxford)<\/em><\/td>\n<\/tr>\n\n11:00<\/strong><\/td>\nLecture 2: <\/strong>Prof Greg Challis (University of Warwick)<\/em><\/td>\n<\/tr>\n\n11:20<\/strong><\/td>\nLecture 3:<\/strong> Dr Paul Brennan (Structural Genomics Consortium)<\/em><\/td>\n<\/tr>\n\n12:15<\/strong><\/td>\nLunch<\/strong><\/td>\n<\/tr>\n\n13:30<\/strong><\/td>\nDiscussion session 1: 1000 Click Reactions<\/strong><\/td>\n<\/tr>\n\n14:15<\/strong><\/td>\nDiscussion session 2: Create scaffold diversity using academic research<\/strong><\/td>\n<\/tr>\n\n15:00<\/strong><\/td>\nTea\/coffee<\/strong><\/td>\n<\/tr>\n\n15:30<\/strong><\/td>\nDiscussion session 3: Tools to enable academics to contribute to drug discovery<\/strong><\/td>\n<\/tr>\n\n16:15<\/strong><\/td>\nDiscussion forum: IP issues<\/strong><\/td>\n<\/tr>\n\n16:30<\/strong><\/td>\nConclusions and close of meeting<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n <\/p>\n
\n\n\n<\/a><\/td>\n <\/a><\/td>\n <\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
<\/a><\/h3>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\nA Dial-a-Molecule EPSRC Grand Challenge theme event<\/h3>\n
When:<\/strong> 5 February 2013<\/em>
\nWhere:<\/strong> 3M Buckley Innovation Centre, University of Huddersfield (http:\/\/www.3mbic.com\/)<\/em><\/p>\nThe last 10 years have seen a radical restructuring of global pharma R&D in response to the increasingly challenging process of discovering, progressing and launching a new drug. A consequence of this business remodelling has been the tapering of UK synthetic and medicinal chemistry capacity; this offers an opportunity for academic synthetic chemists to generate impact in the drug discovery process, especially in the hit\/lead identification phase of the drug pipeline. The 3D Fragment Consortium is an EPSRC-funded network, which aims to expand the chemical space of drug discovery by leveraging novel class-leading academic synthetic chemistry. Access to such cutting-edge synthetic expertise will empower and enable the study of drug target classes previously lacking high quality chemical start points; such as protein-protein interactions. Given the UK strength in chemical synthesis, a chemical consortium focused upon the implementation of powerful synthetic methods would be perfectly placed to design and deliver novel three-dimensional chemical libraries for fragment screening to complement existing fragment libraries. The consortium would also be able to contribute to the generation of useful chemical start points for a broad range of target therapeutic classes.<\/p>\n
As part of the Royal Socie<\/strong>ty Year of Science and Indu<\/strong>stry<\/strong>, and in collaboration with the \u2018Dial-a-Molecule\u2019 EPSRC Grand Challenge Network<\/strong> and SMSDrug.net<\/strong>, on 5 February 2013 the 3D Fragment Consortium<\/strong> will host a workshop meeting at which the opportunities and benefits for academic synthetic chemists will be presented. In particular, the workshop will discuss:
\n\u2022\u00a0\u00a0 \u00a0how class-leading academic synthesis can be used in a drug discovery context
\n\u2022\u00a0\u00a0 \u00a0the key features of fragment libraries, and their relevance to cutting-edge research groups
\n\u2022\u00a0\u00a0 \u00a0the tools available to enable synthetic chemists to make contributions to the drug discovery process
\n\u2022\u00a0\u00a0 \u00a0constructing an inclusive network of med chem-facing academic chemists
\n\u2022\u00a0\u00a0 \u00a0funding possibilities
\n\u2022\u00a0\u00a0 \u00a0how to deal with IP issues<\/p>\nThe key deliverable of the event will be the creation of a blueprint for successful collaborations between academic chemists and drug-hunting organisations.<\/p>\n
Program:<\/strong><\/span><\/p>\n\n\n\n10:00<\/strong><\/td>\nRegistration<\/strong><\/td>\n<\/tr>\n\n10:30<\/strong><\/td>\nOpening remarks<\/strong><\/td>\n<\/tr>\n\n<\/td>\n Joe Sweeney & Andy Morley<\/em><\/td>\n<\/tr>\n\n10:40<\/strong><\/td>\nLecture 1:<\/strong> Dr Stuart Conway (University of Oxford)<\/em><\/td>\n<\/tr>\n\n11:00<\/strong><\/td>\nLecture 2: <\/strong>Prof Greg Challis (University of Warwick)<\/em><\/td>\n<\/tr>\n\n11:20<\/strong><\/td>\nLecture 3:<\/strong> Dr Paul Brennan (Structural Genomics Consortium)<\/em><\/td>\n<\/tr>\n\n12:15<\/strong><\/td>\nLunch<\/strong><\/td>\n<\/tr>\n\n13:30<\/strong><\/td>\nDiscussion session 1: 1000 Click Reactions<\/strong><\/td>\n<\/tr>\n\n14:15<\/strong><\/td>\nDiscussion session 2: Create scaffold diversity using academic research<\/strong><\/td>\n<\/tr>\n\n15:00<\/strong><\/td>\nTea\/coffee<\/strong><\/td>\n<\/tr>\n\n15:30<\/strong><\/td>\nDiscussion session 3: Tools to enable academics to contribute to drug discovery<\/strong><\/td>\n<\/tr>\n\n16:15<\/strong><\/td>\nDiscussion forum: IP issues<\/strong><\/td>\n<\/tr>\n\n16:30<\/strong><\/td>\nConclusions and close of meeting<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n <\/p>\n
\n\n\n<\/a><\/td>\n <\/a><\/td>\n <\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
\nWhere:<\/strong> 3M Buckley Innovation Centre, University of Huddersfield (http:\/\/www.3mbic.com\/)<\/em><\/p>\n
The last 10 years have seen a radical restructuring of global pharma R&D in response to the increasingly challenging process of discovering, progressing and launching a new drug. A consequence of this business remodelling has been the tapering of UK synthetic and medicinal chemistry capacity; this offers an opportunity for academic synthetic chemists to generate impact in the drug discovery process, especially in the hit\/lead identification phase of the drug pipeline. The 3D Fragment Consortium is an EPSRC-funded network, which aims to expand the chemical space of drug discovery by leveraging novel class-leading academic synthetic chemistry. Access to such cutting-edge synthetic expertise will empower and enable the study of drug target classes previously lacking high quality chemical start points; such as protein-protein interactions. Given the UK strength in chemical synthesis, a chemical consortium focused upon the implementation of powerful synthetic methods would be perfectly placed to design and deliver novel three-dimensional chemical libraries for fragment screening to complement existing fragment libraries. The consortium would also be able to contribute to the generation of useful chemical start points for a broad range of target therapeutic classes.<\/p>\n
As part of the Royal Socie<\/strong>ty Year of Science and Indu<\/strong>stry<\/strong>, and in collaboration with the \u2018Dial-a-Molecule\u2019 EPSRC Grand Challenge Network<\/strong> and SMSDrug.net<\/strong>, on 5 February 2013 the 3D Fragment Consortium<\/strong> will host a workshop meeting at which the opportunities and benefits for academic synthetic chemists will be presented. In particular, the workshop will discuss: The key deliverable of the event will be the creation of a blueprint for successful collaborations between academic chemists and drug-hunting organisations.<\/p>\n Program:<\/strong><\/span><\/p>\n <\/p>\n
\n\u2022\u00a0\u00a0 \u00a0how class-leading academic synthesis can be used in a drug discovery context
\n\u2022\u00a0\u00a0 \u00a0the key features of fragment libraries, and their relevance to cutting-edge research groups
\n\u2022\u00a0\u00a0 \u00a0the tools available to enable synthetic chemists to make contributions to the drug discovery process
\n\u2022\u00a0\u00a0 \u00a0constructing an inclusive network of med chem-facing academic chemists
\n\u2022\u00a0\u00a0 \u00a0funding possibilities
\n\u2022\u00a0\u00a0 \u00a0how to deal with IP issues<\/p>\n\n\n
\n 10:00<\/strong><\/td>\n Registration<\/strong><\/td>\n<\/tr>\n \n 10:30<\/strong><\/td>\n Opening remarks<\/strong><\/td>\n<\/tr>\n \n <\/td>\n Joe Sweeney & Andy Morley<\/em><\/td>\n<\/tr>\n \n 10:40<\/strong><\/td>\n Lecture 1:<\/strong> Dr Stuart Conway (University of Oxford)<\/em><\/td>\n<\/tr>\n \n 11:00<\/strong><\/td>\n Lecture 2: <\/strong>Prof Greg Challis (University of Warwick)<\/em><\/td>\n<\/tr>\n \n 11:20<\/strong><\/td>\n Lecture 3:<\/strong> Dr Paul Brennan (Structural Genomics Consortium)<\/em><\/td>\n<\/tr>\n \n 12:15<\/strong><\/td>\n Lunch<\/strong><\/td>\n<\/tr>\n \n 13:30<\/strong><\/td>\n Discussion session 1: 1000 Click Reactions<\/strong><\/td>\n<\/tr>\n \n 14:15<\/strong><\/td>\n Discussion session 2: Create scaffold diversity using academic research<\/strong><\/td>\n<\/tr>\n \n 15:00<\/strong><\/td>\n Tea\/coffee<\/strong><\/td>\n<\/tr>\n \n 15:30<\/strong><\/td>\n Discussion session 3: Tools to enable academics to contribute to drug discovery<\/strong><\/td>\n<\/tr>\n \n 16:15<\/strong><\/td>\n Discussion forum: IP issues<\/strong><\/td>\n<\/tr>\n \n 16:30<\/strong><\/td>\n Conclusions and close of meeting<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n \n\n
\n ![\"SMSDrugNet-logo\"](\"https:\/\/i0.wp.com\/generic.wordpress.soton.ac.uk\/dial-a-molecule\/wp-content\/blogs.dir\/sites\/50\/2013\/02\/UniHudd-logo.png\"){kind=logo}
<\/a><\/td>\n<\/a><\/td>\n<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"